Security readout for executives and security teams
Plain-English summary
This flaw affects B. Braun medical connectivity components and can let an unauthenticated remote attacker read sensitive information and potentially gain higher privileges. The known evidence supports high confidentiality risk, not confirmed active exploitation. Treat exposed or unmanaged affected devices as a priority because these products may sit near infusion workflows.
Executive priority
Prioritize this as a high-risk medical device connectivity issue. It is not confirmed exploited, but unauthenticated remote access to sensitive information near infusion infrastructure justifies timely inventory, network restriction, and vendor-guided remediation.
Technical view
CVE-2020-25162 is an XPath injection issue in B. Braun SpaceCom L81/U61 and earlier and Data module compactplus A10/A11. The CVSS 3.1 vector is AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N, meaning network-reachable, low-complexity, unauthenticated exploitation with high confidentiality impact.
Likely exposure
Exposure is most likely in healthcare environments using B. Braun SpaceCom, Battery Pack SP with Wi-Fi, or Data module compactplus connectivity. Risk rises if these devices are reachable from broad internal networks or remote access paths. The bundle does not prove internet exposure or list exact fixed versions.
Exploitation context
The source bundle does not identify public exploit code or active exploitation, and the CVE is not marked as CISA KEV. The vulnerability class is remotely reachable and unauthenticated, so exploitation feasibility is concerning even without evidence of current attacks.
Researcher notes
Evidence is limited to public CVE, CISA, and vendor advisory references in the bundle. Do not assume impact beyond sensitive information access and privilege escalation. Validate exact product versions and remediation options directly against B. Braun guidance before making operational changes.
Mitigation direction
- Identify affected B. Braun devices and firmware versions in clinical networks.
- Check B. Braun advisory for product-specific remediation or upgrade guidance.
- Review CISA ICSMA-20-296-02 for vendor-approved mitigations.
- Limit network reachability to trusted management and clinical systems only.
- Prioritize compensating controls where immediate updates are unavailable.
Validation and detection
- Inventory SpaceCom, Battery Pack SP with Wi-Fi, and Data module compactplus deployments.
- Compare versions against SpaceCom L81/U61 or earlier and compactplus A10/A11.
- Confirm affected devices are not reachable from untrusted networks.
- Verify remediation status against B. Braun and CISA advisory guidance.
- Review access logs for unusual unauthenticated access, where logging exists.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-643: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2020-25162 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 7.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N3.93.6Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
7.5HighVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Source materials
- CVE List V5 sourceCVE List V5
- https://www.cisa.gov/uscert/ics/advisories/icsma-20-296-02CVE reference · x_refsource_CONFIRM
- https://www.bbraun.com/en/products-and-therapies/services/b-braun-vulnerability-disclosure-policy/security-advisory.htmlCVE reference · x_refsource_CONFIRM
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization of Data within XPath Expressions ('XPath Injection')
Improper Neutralization of Data within XPath Expressions ('XPath Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.